XML 102 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
Information by segment and main country - Reconciliation from net income to Adjusted EBITA (Detail) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Information by segment and main country [Line Items]      
Profit (loss) € (463) [1] € (1,605) [2] € 3,323 [2]
Profit (loss) from discontinued operations (10) [2] 13 [2] 2,711 [1]
Tax expense (income) (73) (113) (103)
Share of profit (loss) of associates and joint ventures accounted for using equity method (98) (2) (4)
Finance costs 376 258 188
Finance income 63 58 149
Profit (loss) from operating activities (115) (1,529) 553
Amortization of acquired intangible assets [2] 290 363 322
Impairment loss recognised in profit or loss, goodwill [2] 8 1,357 15
Earnings before interest, taxes and amortization 183 192 890
Restructuring and acquisition-related charges [2] 381 202 95
Other items [2] 1,358 925 1,069
Adjusted EBITA 1,921 1,318 2,054
Respironics litigation provision [Member]      
Information by segment and main country [Line Items]      
Other items [2] 575    
Respironics field-action connected to the anticipated consent decree [Member]      
Information by segment and main country [Line Items]      
Other items [2] 363 250 719
Respironics field-action running remediation costs [Member]      
Information by segment and main country [Line Items]      
Other items [2] 224 210 94
Quality remediation actions [Member]      
Information by segment and main country [Line Items]      
Other items [2] 175 59 94
Provision for a legal matter [Member]      
Information by segment and main country [Line Items]      
Other items [2] 31    
Investment re-measurement loss [Member]      
Information by segment and main country [Line Items]      
Other items [2] 23    
Gain on divestment of business [Member]      
Information by segment and main country [Line Items]      
Other items [2] (35)    
Remaining items [Member]      
Information by segment and main country [Line Items]      
Other items [2] 2 63 87
R&D project impairments [Member]      
Information by segment and main country [Line Items]      
Other items [2]   134  
Portfolio realignment charges [Member]      
Information by segment and main country [Line Items]      
Other items [2]   109  
Provision for public investigations tender irregularities [Member]      
Information by segment and main country [Line Items]      
Other items [2]   60  
Impairment of assets in S&RC [Member]      
Information by segment and main country [Line Items]      
Other items [2]   39  
Loss on divestment of business [Member]      
Information by segment and main country [Line Items]      
Other items [2]     76
Diagnosis & Treatment [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities 720 538 948
Amortization of acquired intangible assets 89 115 142
Impairment loss recognised in profit or loss, goodwill 8   2
Earnings before interest, taxes and amortization 816 652 1,092
Restructuring and acquisition-related charges 118 3 (30)
Other items 92 133 (35)
Adjusted EBITA 1,026 788 1,028
Diagnosis & Treatment [Member] | Quality remediation actions [Member]      
Information by segment and main country [Line Items]      
Other items 81    
Diagnosis & Treatment [Member] | Remaining items [Member]      
Information by segment and main country [Line Items]      
Other items 11 0 (35)
Diagnosis & Treatment [Member] | R&D project impairments [Member]      
Information by segment and main country [Line Items]      
Other items   73  
Diagnosis & Treatment [Member] | Provision for public investigations tender irregularities [Member]      
Information by segment and main country [Line Items]      
Other items   60  
Connected Care [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities (1,199) (2,347) (716)
Amortization of acquired intangible assets 178 226 158
Impairment loss recognised in profit or loss, goodwill 0 1,357 13
Earnings before interest, taxes and amortization (1,020) (764) (545)
Restructuring and acquisition-related charges 115 125 130
Other items 1,275 750 968
Adjusted EBITA 369 111 553
Connected Care [Member] | Respironics litigation provision [Member]      
Information by segment and main country [Line Items]      
Other items 575    
Connected Care [Member] | Respironics field-action connected to the anticipated consent decree [Member]      
Information by segment and main country [Line Items]      
Other items 363 250 719
Connected Care [Member] | Respironics field-action running remediation costs [Member]      
Information by segment and main country [Line Items]      
Other items 224 210 94
Connected Care [Member] | Quality remediation actions [Member]      
Information by segment and main country [Line Items]      
Other items 94 59 94
Connected Care [Member] | Provision for a legal matter [Member]      
Information by segment and main country [Line Items]      
Other items 31    
Connected Care [Member] | Remaining items [Member]      
Information by segment and main country [Line Items]      
Other items (12) 24 61
Connected Care [Member] | R&D project impairments [Member]      
Information by segment and main country [Line Items]      
Other items   59  
Connected Care [Member] | Portfolio realignment charges [Member]      
Information by segment and main country [Line Items]      
Other items   109  
Connected Care [Member] | Impairment of assets in S&RC [Member]      
Information by segment and main country [Line Items]      
Other items   39  
Personal Health [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities 552 515 576
Amortization of acquired intangible assets 14 15 15
Earnings before interest, taxes and amortization 567 531 591
Restructuring and acquisition-related charges 9 11 (1)
Other items 22 (4) 0
Adjusted EBITA 597 538 590
Personal Health [Member] | Investment re-measurement loss [Member]      
Information by segment and main country [Line Items]      
Other items 23    
Personal Health [Member] | Remaining items [Member]      
Information by segment and main country [Line Items]      
Other items (1) (6) 0
Personal Health [Member] | R&D project impairments [Member]      
Information by segment and main country [Line Items]      
Other items   3  
Other [Member]      
Information by segment and main country [Line Items]      
Profit (loss) from operating activities (188) (235) (255)
Amortization of acquired intangible assets 9 8 6
Earnings before interest, taxes and amortization (179) (227) (248)
Restructuring and acquisition-related charges 140 62 (5)
Other items (32) 46 136
Adjusted EBITA (71) (119) (117)
Other [Member] | Gain on divestment of business [Member]      
Information by segment and main country [Line Items]      
Other items (35)    
Other [Member] | Remaining items [Member]      
Information by segment and main country [Line Items]      
Other items € 3 € 46 61
Other [Member] | Loss on divestment of business [Member]      
Information by segment and main country [Line Items]      
Other items     € 76
[1] Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.
[2] Shareholders in this table refers to shareholders of Koninklijke Philips N.V. Per share calculations have been adjusted retrospectively for all periods presented to reflect the issuance of shares for the share dividend in respect of 2022.